Jeil Pharmaceutical Co., Ltd. (KOSE:A002620) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of shares pursuant to a trust contract with Mirae Asset Securities Co., Ltd. The purpose of the share repurchase program is to stabilize the share price and to enhance shareholder value. The share repurchase program is valid until August 27, 2016.

As of August 27, 2015, the company had 2,008,619 shares in treasury within scope available for dividend and no shares in treasury through other repurchase.